Last reviewed · How we verify
NCT03957044
the Effect of Vestibular Rehabilitation in Autistic Children
NA trial testing The education of sensory integration with vestibular education in Autistic Spectrum Disorder in 22 participants. Completed in 1 July 2013.
1 June 2013
Quick facts
| Lead sponsor | Istinye University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 22 |
| Start date | 1 March 2013 |
| Primary completion | 1 June 2013 |
| Estimated completion | 1 July 2013 |
Drugs / interventions tested
- The education of sensory integration with vestibular education
Conditions studied
- Autistic Spectrum Disorder — all drugs for Autistic Spectrum Disorder →
- Vestibular Disorder — all drugs for Vestibular Disorder →
- Sensory Integration Disorder — all drugs for Sensory Integration Disorder →
Sponsor
Istinye University
Who can join
Adults 3 to 10, any sex, with Autistic Spectrum Disorder or Vestibular Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study was conducted to clarify the effect of vestibular education for autistic children on "sensory profile" and "postrotary nystagmus". In the study, the results of the two groups were compared through the treatment of sensory integration: the once who got the education and the once who did not. For this study, 26 autistic children were included who joined the " Çatalca District Unit of Disabled the Project of No Disabilities ", who was diagnosed with autism, who was 3-10 years (older than 36 months younger than 11 years). For each child, the analysis of the sensory integration and nystagmus was applied twice; at the beginning and at the end of the research. At the beginning of the research, the children were divided into two groups randomly drawn by lots. The first group was given the education of sensory integration with vestibular education and the second group was given the education of sensory integration without vestibular education. Both groups were educated for 10 weeks, 2 days a week with 40- minute sessions.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03957044
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Autistic Spectrum Disorder
Currently open trials in the same condition.
- NCT05910502 — Project AFECT (Autism Family Empowerment Coaching and Training Program) · NA · active not recruiting
- NCT05492032 — Cumulative and Booster Effects of Multisession Prefrontal Transcranial Direct Current Stimulation in Adolescents With AS · NA · recruiting
Other Istinye University trials
Trials by the same sponsor.
- NCT06963294 — Ketamine and Dexmedetomidine for Delirium in Joint Arthroplasty · NA · not yet recruiting
- NCT07528807 — Exercise, Pain Beliefs, and Activity Patterns in Musculoskeletal Pain · not yet recruiting
- NCT07520981 — Functional Capacity, Subjective Dyspnea and Fatigue in Smokers · not yet recruiting
- NCT07518095 — Serum Bicarbonate and Enteral Feeding Intolerance in Adult ICU: A Prospective Clinical Trial · not yet recruiting
- NCT07483190 — Effectiveness of Thoracoabdominal Nerve Block (M-TAPA) on Postoperative Pain Relief in Laparoscopic Hysterectomy · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03957044 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Istinye University
- Last refreshed: 30 July 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03957044.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing